NeoGenomics Inc.

NASDAQ: NEO · Real-Time Price · USD
6.21
0.01 (0.16%)
At close: Aug 15, 2025, 3:59 PM
6.29
1.21%
After-hours: Aug 15, 2025, 06:17 PM EDT

NeoGenomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
181.33M 168.03M 172M 167.82M 164.5M 156.24M 155.55M 151.95M 146.92M 137.22M 138.71M 128.78M 125.07M 117.17M 125.73M 121.34M 121.72M 115.53M
Cost of Revenue
104.07M 94.79M 94.74M 92.94M 95.46M 94.22M 87.96M 89.64M 87.03M 82.41M 81.88M 79.89M 81.13M 78.94M 80.47M 74.1M 68.73M 73.96M
Gross Profit
77.26M 73.25M 77.26M 74.88M 69.04M 62.02M 67.59M 62.31M 59.89M 54.81M 56.83M 48.89M 43.95M 38.23M 45.26M 47.24M 52.99M 41.57M
Operating Income
-47.63M -27.82M -18.4M -21.2M -20.4M -30.57M -18.57M -24.2M -29.89M -35.07M -26.38M -39.51M -39.7M -52.03M -41.57M -39.71M -22.37M -15.11M
Interest Income
-2.26M 3.72M 4.33M 4.67M 4.59M 4.83M 4.84M 4.53M 4.31M 3.22M 860K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-45.09M -25.66M -16.13M -17.85M -19.02M -27.68M -15.29M -21.45M -26.64M -33.72M -25.52M -39.62M -41.03M -53.16M -44.2M -23.17M 73.44M -21.14M
Net Income
-45.09M -25.92M -15.32M -17.7M -18.64M -27.06M -14.33M -18.52M -24.33M -30.8M -22.69M -36.85M -35.3M -49.41M -41.76M -20.35M 75.87M -22.11M
Selling & General & Admin
95.82M 90.89M 85.98M 87.38M 85M 86.02M 77.83M 79.1M 79.21M 77.81M 72.02M 81.09M 75.02M 82.55M 78.31M 79.54M 71.86M 54.23M
Research & Development
9.02M 10.18M 7.97M 7.68M 7.89M 7.62M 7.13M 5.29M 7.5M 7.39M 6.67M 7.31M 8.63M 7.71M 8.51M 7.41M 3.5M 2.46M
Other Expenses
n/a n/a 1.71M 1.01M 1.54M 2.4M 1.21M 2.13M n/a 4.68M -1K 25K -405K 168K n/a 89K 171K n/a
Operating Expenses
104.84M 101.07M 95.66M 96.08M 94.44M 96.04M 86.16M 86.51M 86.71M 89.89M 81.67M 88.4M 83.65M 90.26M 86.82M 86.95M 75.36M 56.68M
Interest Expense
933K 1.62M 1.62M 1.64M 1.67M 1.69M 1.68M 1.69M 1.78M 1.76M n/a 139K 926K 1.3M 1.71M 1.3M 902K 1.18M
Selling & Marketing Expenses
24.07M 22.68M 22.34M 20.41M 21.68M 20.22M 18.07M 17.61M 18.9M 16.26M 17.14M 16.81M 17.07M 16.3M 15.92M 15.7M 17.22M 13.75M
Cost & Expenses
208.92M 195.86M 190.4M 189.02M 186.44M 186.81M 174.13M 176.15M 173.74M 172.29M 163.55M 168.29M 164.77M 169.2M 167.3M 161.05M 144.09M 130.64M
Income Tax Expense
n/a 266K -804K -150K -375K -620K -960K -2.94M -2.31M -2.92M -2.84M -2.77M -5.73M -3.75M -2.44M -2.82M -2.44M 976K
Shares Outstanding (Basic)
25.59M 25.48M 25.33M 25.39M 25.28M 25.22M 25.19M 25.14M 25.07M 25.01M 24.94M 24.57M 24.81M 24.7M 24.52M 23.94M 23.66M 23.24M
Shares Outstanding (Diluted)
25.59M 25.48M 25.33M 25.39M 25.28M 25.22M 25.19M 25.14M 25.07M 25.01M 24.94M 24.89M 24.81M 24.73M 24.62M 24.51M 26.25M 23.24M
EPS (Basic)
-1.75 -1 -0.6 -0.7 -0.75 -1.05 -0.55 -0.75 -0.95 -1.25 -0.9 -1.5 -1.4 -2 -1.7 -0.85 3.20 -0.95
EPS (Diluted)
-1.75 -1 -0.6 -0.7 -0.75 -1.05 -0.55 -0.75 -0.95 -1.25 -0.9 -1.5 -1.4 -2 -1.7 -0.85 2.95 -0.95
EBITDA
-47.63M -6.31M 3.68M 1.78M 756K -7.73M 4.76M -1.63M -6.6M -14.13M -8.32M -22.05M -20.75M -32.32M -25.64M -2.81M -11.67M -8.96M
EBIT
n/a -24.04M -14.5M -16.21M -17.35M -26M -13.61M -22.46M -24.86M -31.96M -26.38M -39.48M -40.11M -51.86M -42.5M -21.87M -22.37M -19.96M
Depreciation & Amortization
n/a 17.73M 18.19M 17.98M 18.11M 18.27M 18.36M 18.13M 20.58M 17.83M 20.47M 17.46M 17.02M 16.89M 16.86M 19.07M 12.59M 11M